{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:26:20Z","timestamp":1760235980780,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"20","license":[{"start":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T00:00:00Z","timestamp":1634515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ovarian cancer has the lowest survival rate in gynaecologic malignancies with a 5-year survival rate of 43%. Platinum resistance is one of the main drivers of ovarian cancer mortality, of which aberrant methylation has been cited as a significant contributor. Understanding the essential role of the methylenetetrahydrofolate reductase enzyme (MTHFR) on DNA synthesis and repair, and how nutrient status can vastly affect its performance, led to the investigation of MTHFR status and dietary influence on platinum response in epithelial ovarian cancer (EOC) patients. Twenty-five adult female patients who completed first-line platinum-based chemotherapy for primary ovarian cancer were selected from Icon Cancer Centres in Australia. Participants were grouped based on platinum response. A full medical and family history, food frequency questionnaire and single blood test were completed, testing for MTHFR polymorphisms, serum folate, serum and active B12 and homocysteine levels. Nineteen of twenty-five participants had an MTHFR polymorphism. Of those, 20% were compound heterozygous, 12% were heterozygous C677T (CT), 4% homozygous C677T, 12% homozygous A1298C and 28% were heterozygous A1298C (AC). Statistically significant associations were found between dietary zinc (p = 0.0086; 0.0030; 0.0189) and B12 intakes in CT genotypes (p = 0.0157; 0.0030; 0.0068) indicating that zinc or vitamin B12 intakes below RDI were associated with this genotype. There were strong associations of vitamin B6 intakes in AC genotypes (p = 0.0597; 0.0547; 0.0610), and dietary folate in compound heterozygotes with sensitive and partially sensitive disease (p = 0.0627; 0.0510). There were also significant associations between serum folate (p = 0.0478) and dietary B12 (p = 0.0350) intakes above RDI and platinum sensitivity in wild-types as well as strong associations with homocysteine levels (p = 0.0886) and zinc intake (p = 0.0514). Associations with dietary B12 (p = 0.0514) and zinc intakes (p = 0.0731) were also strong in resistant wild types. Results indicate that dietary zinc, B12 and B6 intakes may be associated with platinum sensitivity dependent on MTHFR genotype. These results require further research to clarify the dosages necessary to elicit a response; however, they provide a novel foundation for acknowledging the role of diet on treatment response in EOC.<\/jats:p>","DOI":"10.3390\/cancers13205215","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T16:43:55Z","timestamp":1634575435000},"page":"5215","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Retrospective Cross-Sectional Cohort Trial Assessing the Prevalence of MTHFR Polymorphisms and the Influence of Diet on Platinum Resistance in Ovarian Cancer Patients"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-633X","authenticated-orcid":false,"given":"Caitlin","family":"Phillips-Chavez","sequence":"first","affiliation":[{"name":"Icon Cancer Centre, Queensland, Australia"},{"name":"Endeavour College of Natural Health, Brisbane, QLD 4006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jermaine","family":"Coward","sequence":"additional","affiliation":[{"name":"Icon Cancer Centre, Queensland, Australia"},{"name":"School of Medicine, University of Queensland, Brisbane, QLD 4006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Watson","sequence":"additional","affiliation":[{"name":"Endeavour College of Natural Health, Brisbane, QLD 4006, Australia"},{"name":"Institute of Health & Biomedical Innovation, Queensland University of Technology, Brisbane, QLD 4006, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1643-6215","authenticated-orcid":false,"given":"Janet","family":"Schloss","sequence":"additional","affiliation":[{"name":"NCNM, Southern Cross University, Lismore, NSW 2480, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking Ovarian Cancer: Recommendations for Improving Outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_2","unstructured":"The World Ovarian Cancer Coalition (2019, June 23). The World Ovarian Cancer Coalition Atlas Global Trends in Incidence, Mortality and Survival. Available online: https:\/\/worldovariancancercoalition.org\/wp-content\/uploads\/2018\/10\/THE-WORLD-OVARIAN-CANCER-COALITION-ATLAS-2018.pdf."},{"key":"ref_3","unstructured":"Australian Institute of Health and Welfare, and Cancer Australia (2012). Gynaecological Cancers in Australia: An Overview, Cancer Australia."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1758835918768232","DOI":"10.1177\/1758835918768232","article-title":"First-line treatment of ovarian cancer: Questions and controversies to address","volume":"10","author":"Ledermann","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/IGC.0b013e31823de6ae","article-title":"Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: Analysis of the OVCAD data","volume":"22","author":"Polterauer","year":"2012","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"viii7","DOI":"10.1093\/annonc\/mdi961","article-title":"2004 consensus statements on the management of ovarian cancer: Final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","volume":"16","author":"Quinn","year":"2005","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1124\/pr.111.005637","article-title":"Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes","volume":"64","author":"Shen","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1158\/1078-0432.CCR-07-2238","article-title":"Platinum Resistance: The Role of DNA Repair Pathways","volume":"14","author":"Martin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/mmr.2014.2221","article-title":"DNA methylation profiles in ovarian cancer: Implication in diagnosis and therapy (Review)","volume":"10","author":"Koukoura","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/IGC.0b013e31821b2568","article-title":"2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer Report From the Fourth Ovarian Cancer Consensus Conference","volume":"21","author":"Stuart","year":"2011","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/annonc\/mdw663","article-title":"5th Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recurrent Disease","volume":"28","author":"Wilson","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rizzo, A., Napoli, A., Roggiani, F., Tomassetti, A., Bagnoli, M., and Mezzanzanica, D. (2018). One-carbon metabolism: Biological players in epithelial ovarian cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19072092"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fonc.2016.00153","article-title":"Choline metabolism alteration: A focus on ovarian cancer","volume":"6","author":"Bagnoli","year":"2016","journal-title":"Front. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Drug Resistance Updates Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updates"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1515\/cclm-2012-0561","article-title":"Molecular mechanisms underlying the potentially adverse effects of folate","volume":"51","author":"Strickland","year":"2013","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2119\/molmed.2010.00243","article-title":"GNMT expression increases hepatic folate contents and folate-dependent methionine synthase-mediated homocysteine remethylation","volume":"17","author":"Wang","year":"2011","journal-title":"Mol. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1476-4598-12-138","article-title":"Ets-1 regulates intracellular glutathione levels: Key target for resistant ovarian cancer","volume":"12","author":"Verschoor","year":"2013","journal-title":"Mol. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13045-018-0645-x","article-title":"The roles of metallothioneins in carcinogenesis","volume":"11","author":"Si","year":"2018","journal-title":"J. Hematol. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: Emerging patterns and implications","volume":"13","author":"Feil","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/bs.acc.2015.07.002","article-title":"Homocysteine in Chronic Kidney Disease","volume":"72","author":"Ostrakhovitch","year":"2015","journal-title":"Adv. Clin. Chem."},{"key":"ref_21","unstructured":"Schwahn, B.C., and Rozen, R. (2019, January 17). Methylenetetrahydrofolate Reductase Polymorphisms: Pharmacogenetic Effects, Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK5968\/."},{"key":"ref_22","unstructured":"(2019, February 04). Iverson Genetic Diagnostics Incorporated MTHFR Panel. Available online: http:\/\/www.iversongenetics.com\/mthfr.html."},{"key":"ref_23","first-page":"1822","article-title":"Epigenetics of Male Infertility: The Role of DNA Methylation","volume":"9","author":"Bogdanovic","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jcmm.12032","article-title":"Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and promoter methylation in cervical oncogenic lesions and cancer","volume":"17","author":"Botezatu","year":"2013","journal-title":"J. Cell. Mol. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3892\/ol.2016.4608","article-title":"Integration and bioinformatics analysis of DNA-methylated genes associated with drug resistance in ovarian cancer","volume":"12","author":"Yan","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.aninu.2015.09.002","article-title":"Epigenetic modulation of DNA methylation by nutrition and its mechanisms in animals","volume":"1","author":"Zhang","year":"2015","journal-title":"Anim. Nutr."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/cga.12232","article-title":"Genetic polymorphisms and folate status","volume":"57","author":"Hiraoka","year":"2017","journal-title":"Congenit. Anom."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1748-1716.2011.02278.x","article-title":"Diet induced epigenetic changes and their implications for health","volume":"202","author":"Mckay","year":"2011","journal-title":"Acta Physiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.leu.2404575","article-title":"Folate restriction and methylenetetrahydrofolate reductase 677T polymorphism decreases adoMet synthesis via folate-dependent remethylation in human-transformed lymphoblasts","volume":"21","author":"Chiang","year":"2007","journal-title":"Leukemia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1038\/cddis.2013.405","article-title":"Zinc chelation: A metallothionein 2A\u2019s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance","volume":"4","author":"Habel","year":"2013","journal-title":"Cit. Cell Death Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-200059004-00001","article-title":"Preclinical Perspectives on Platinum Resistance","volume":"59","author":"Kelland","year":"2000","journal-title":"Drugs"},{"key":"ref_32","first-page":"17","article-title":"Biomarkers of Platinum Resistance in Serous Ovarian Cancer","volume":"3","author":"Zaporozhan","year":"2018","journal-title":"World Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.febslet.2006.01.036","article-title":"Interaction of metallothionein with tumor suppressor p53 protein","volume":"580","author":"Ostrakhovitch","year":"2006","journal-title":"FEBS Lett."},{"key":"ref_34","first-page":"237","article-title":"MTHFR genetic testing: Controversy and clinical implications","volume":"45","author":"Long","year":"2016","journal-title":"Aust. Fam. Physician"},{"key":"ref_35","unstructured":"(2018, May 04). Cancer Council Victoria Food Frequency Questionnaires\u2014Cancer Council Victoria v3.2. Available online: https:\/\/www.cancervic.org.au\/research\/epidemiology\/nutritional_assessment_services."},{"key":"ref_36","unstructured":"(2018, April 30). FACIT.org FACT-O\u2014Functional Assessment of Cancer Therapy\u2014Ovarian Cancer. Available online: https:\/\/eprovide.mapi-trust.org\/instruments\/functional-assessment-of-cancer-therapy-ovarian-cancer."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1757-2215-6-17","article-title":"Longitudinal health-related quality of life assessment: Implications for prognosis in ovarian cancer","volume":"6","author":"Gupta","year":"2013","journal-title":"J. Ovarian Res."},{"key":"ref_38","unstructured":"(2019, January 28). Australian Government Department of Health Healthy Weight and You\u2014Your Information Booklet, Available online: http:\/\/healthyweight.health.gov.au\/wps\/wcm\/connect\/healthyweight\/9aa254c4-e7b0-4584-9c15-a185c5791a4b\/FINAL+booklet+for+upload+%28D14-550905%29.PDF?MOD=AJPERES."},{"key":"ref_39","unstructured":"(2019, February 02). Statistics\u2014Ovarian Cancer Research Alliance. Available online: https:\/\/ocrahope.org\/patients\/about-ovarian-cancer\/statistics\/."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s13224-012-0284-z","article-title":"Malignant mixed mullerian tumor of the ovary","volume":"64","author":"Gore","year":"2014","journal-title":"J. Obstet. Gynaecol. India"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/PAS.0000000000000476","article-title":"Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers","volume":"39","author":"Mackenzie","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ygyno.2007.10.022","article-title":"The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer","volume":"108","author":"Eisenhauer","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2017.06.007","article-title":"Ovarian cancer: Novel molecular aspects for clinical assessment","volume":"117","author":"Palmirotta","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3945\/an.110.1004","article-title":"Epigenetics: A New Bridge between Nutrition and Health","volume":"1","author":"Choi","year":"2010","journal-title":"Adv. Nutr."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ygyno.2013.12.025","article-title":"Dietary folate and related micronutrients, folate-metabolising genes, and ovarian cancer survival","volume":"132","author":"Dixon","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/jn\/137.9.2114","article-title":"Folic Acid and Vitamin B-12 Smentation Does Not Favorably Influence Uracil Incorporation and Promoter Methylation in Rectal Mucosa DNA of Subjects with Previous Colorectal Adenomas","volume":"137","author":"Pellis","year":"2007","journal-title":"J. Nutr."},{"key":"ref_47","first-page":"3567","article-title":"Alpha-folate Receptor Expression in Epithelial Ovarian Carcinoma and Non-neoplastic Ovarian Tissue","volume":"28","author":"Markert","year":"2008","journal-title":"Anticancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2217\/fon-2017-0379","article-title":"A review of mirvetuximab soravtansine in the treatment of platinum-resistant ovarian cancer","volume":"14","author":"Moore","year":"2018","journal-title":"Futur. Oncol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1038\/sj.onc.1203907","article-title":"Metalloregulation of the tumor suppressor protein p53: Zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells","volume":"19","author":"Richard","year":"2000","journal-title":"Oncogene"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PGP.0000000000000207","article-title":"Molecular alterations of TP53 are a defining feature of ovarian high-grade serous carcinoma: A rereview of cases lacking tp53 mutations in the cancer genome atlas ovarian study","volume":"35","author":"Vang","year":"2016","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12094-012-0894-z","article-title":"Methylation in the p53 promoter in epithelial ovarian cancer","volume":"15","author":"Chmelarova","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ygyno.2008.07.036","article-title":"DNA hypermethylation, Her-2\/neu overexpression and p53 mutations in ovarian carcinoma","volume":"111","author":"Feng","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_54","unstructured":"(2020, July 14). Australian Dietary Guidelines | NHMRC, Available online: https:\/\/www.nhmrc.gov.au\/about-us\/publications\/australian-dietary-guidelines#block-views-block-file-attachments-content-block-1."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12094-018-1978-1","article-title":"SEOM clinical guidelines on nutrition in cancer patients (2018)","volume":"21","author":"Majem","year":"2019","journal-title":"Clin. Transl. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3322\/canjclin.56.6.323","article-title":"Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices. CA","volume":"56","author":"Doyle","year":"2006","journal-title":"Cancer J. Clin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"c214","DOI":"10.1159\/000235241","article-title":"Cohort Studies: Prospective versus Retrospective","volume":"113","author":"Euser","year":"2009","journal-title":"Nephron Clin. Pract."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease","volume":"98","author":"Wilcken","year":"1998","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1617-9625-4-8","article-title":"Tobacco Induced Diseases Smoking status in relation to serum folate and dietary vitamin intake","volume":"4","author":"Vardavas","year":"2008","journal-title":"Tob. Induc. Dis."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5215\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:17:03Z","timestamp":1760167023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/13\/20\/5215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":59,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["cancers13205215"],"URL":"https:\/\/doi.org\/10.3390\/cancers13205215","relation":{},"ISSN":["2072-6694"],"issn-type":[{"type":"electronic","value":"2072-6694"}],"subject":[],"published":{"date-parts":[[2021,10,18]]}}}